Bicarbonate

Bicarbonate

SCHEMBL9519216

C/C=C/C=C(/c1ccc(OC)cc1)c1cccnc1.O=C(O)O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 1/20 0.58
PTAFR P25105 13/20 0.54
KMT2A Q03164 2/20 0.54
CYP1A1 P04798 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP1B1 Q16678 1/20 0.49
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL9520704 1.00 TBXAS1 (0.58) TBXAS1PTAFRKMT2ACYP1A1CYP1A2
SCHEMBL10398993 0.88 PTAFR (0.60) TBXAS1PTAFRKMT2ACYP1A1CYP1A2
SCHEMBL10398977 0.88 PTAFR (0.60) TBXAS1PTAFRKMT2ACYP1A1CYP1A2
SCHEMBL10398976 0.88 PTAFR (0.60) TBXAS1PTAFRKMT2ACYP1A1CYP1A2
Bicarbonate SCHEMBL9523143 0.87 CES2 (0.57) KMT2ACYP1B1RAB9A
Bicarbonate SCHEMBL9522412 0.87 CES2 (0.57) KMT2ACYP1B1RAB9A
Bicarbonate SCHEMBL9521353 0.85 CA1 (0.53) KMT2ACYP1B1RAB9A
SCHEMBL9519210 0.84 TBXAS1 (0.61) TBXAS1PTAFRKMT2A
SCHEMBL9520702 0.84 TBXAS1 (0.61) TBXAS1PTAFRKMT2A
SCHEMBL10398227 0.84 PTAFR (0.62) TBXAS1PTAFRKMT2ACYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0299379-B1 PENTADIENAMIDE PAF-ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1993-04-21 EP disclosed
EP-0299379-A1 Pentadienamide PAF-antagonists F. HOFFMANN-LA ROCHE AG (CH) 1989-01-18 EP disclosed